Machine Learning Ozette Announces $26 Million in Series A Funding for AI-Powered Single-Cell Immune Discovery… AIT News Desk Jul 28, 2022 Ozette’s proprietary technology eliminates manual gridlock and provides unmatched speed, resolution, and reproducibility to unlock immunotherapy…